ClinicalTrials.Veeva

Menu

Food-based Approach Development to Fulfil Amino Acid Gap by Considering the Intestinal Permeability of Children

N

Nia Novita Wirawan

Status

Unknown

Conditions

Stunting

Study type

Observational

Funder types

Other

Identifiers

NCT04157413
l9-10-1169

Details and patient eligibility

About

This study will be comprised of 2 phases. Phase 1 study is a comparative cross-sectional study which will be conducted among children aged 12-24 months living in agricultural area. A total of 172 healthy children consisted of 86 stunted children (Length for age z-score <-2 Standard deviation) and 86 non-stunted children (Length for age z-score ≥0.5 Standard Deviation) will be recruited. Dietary intake, urine and dried blood spot from finger prick will be collected to assess amino acid intake, intestinal permeability and essential blood amino acid respectively. Qualitative study i.e. focus group discussion (FGD) and market survey will also be implemented. According to the result of phase 1 study, 2 types of food-based approaches will be developed, namely Complementary food recommendations (CFR) and Food multi-mix formula

Full description

Phase 1 study will recruit a total of 172 healthy children who are matched by sex and age. Aside of being stunted, children must have normal weight for length z-score (not wasted or overweight). Data collection will be performed as follows:

  1. Dietary intake of the children will be collected by 9 days Estimated Food Record by visiting the respondents house
  2. Urine will be collected once to measure intestinal permeability profile using Lactulose Mannitol ratio indicator.
  3. Dried blood spot from finger prick will be collected to essential blood amino acid.

To collect information on locally available and culturally accepted protein rich food sources, series of focus group discussion (FGD) and market survey will also be implemented.

Food-based approaches will be developed according to the information attained from phase 1 study. Problem nutrients that are identified from dietary assessment will be fulfilled through optimization of locally available food by using linear programming approach. Problem nutrients that are not able to be fulfilled by CFR will be use as a basis to develop a Food multi-mix (FMM) formula. Data of intestinal permeability profile will be used to add other locally available food in FMM that are potential to improve intestinal permeability.

Enrollment

172 estimated patients

Sex

All

Ages

12 to 24 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Stunting group is defined as length for age Z-score (LAZ) <-2.0 SD and non-stunting group as LAZ ≥-0.5 SD
  2. Normal weight for length Z-score (WLZ ≥-2 SD to ≤+1 SD)
  3. Group matching by age, gender
  4. Singleton
  5. Full term gestation
  6. Normal birth weight
  7. Living with mother
  8. Not suffered from diarrhea at least in the last 1 month (as reported by the mothers)
  9. Not suffering from fever during assessment (as measured by the health staff)
  10. Not born from diabetic mothers (as reported by the mothers)

Exclusion criteria

  1. Drink Ultra High Temperature (UHT) milk at least 15 days before urine collection
  2. Taking any medication.
  3. Had taken non-steroidal anti-inflammatory drugs within two weeks of the study,
  4. Taken antibiotics within 4 weeks of the study,
  5. Unable to drink the sugar solution
  6. Refuse to participate until completion of the study

Trial design

172 participants in 2 patient groups

Stunted Group
Description:
A comparative cross sectional study will compare stunted group and non-stunted group on amino acid intake, blood amino acid and intestinal permeability. Stunted group is defined as children who have LAZ \<-2 SD
Non-stunted Group
Description:
Non-stunted group will be those with LAZ \>= 0.5 SD matching by age and sex with stunted group. Other criteria will be similar. No Intervention will be given to the groups in this proposed protocol.

Trial contacts and locations

0

Loading...

Central trial contact

Umi Fahmida, Dr; Nia N Wirawan, MSc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems